Impact of dosing schedule upon suppression of a retrovirus in a murine model of AIDS encephalopathy
- PMID: 8203866
- PMCID: PMC284511
- DOI: 10.1128/AAC.38.3.628
Impact of dosing schedule upon suppression of a retrovirus in a murine model of AIDS encephalopathy
Abstract
We studied the impact of zidovudine (AZT) in Cas-Br-M murine leukemia virus-infected NFS-N mice after administration by once-daily bolus or continuous infusion. While higher peak concentrations of AZT were achieved by once-daily dosing, continuous AZT infusion at 25 micrograms/h maintained levels > 1 microM in plasma and > 0.2 microM in the brain. Continuous infusion provided significantly better viral inhibition, even though total doses were only one-third that of the once-daily therapy group.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
